Epigenetic changes, such as those in DNA methylation, can influence the expression of genes involved in complex conditions like cancer, mood disorders, neurodegenerative diseases, cardiovascular health, and fertility. Emerging tests aim to provide insights into these changes as part of a broader clinical evaluation.
Methylation, an epigenetic process that regulates how genes turn on and off, is at the heart of this ability. Methylation testing offers insights that may assist in earlier diagnosis and personalized treatment planning, potentially improving patient management. As always, results may vary, and methylation testing should be used as part of a broader clinical assessment.
This article explains the science of DNA methylation, reviews the most advanced diagnostic tools available, and provides practical guidance for integrating methylation testing into clinical practice.
Whether you’re a seasoned clinician or just beginning to explore epigenetic testing, this guide is designed to clarify key concepts and help you decide when these tests will benefit your patients.
[signup]
The Clinical Science of DNA Methylation
It’s important to understand what methylation is, and how critical it is to gene expression in health and disease.
What is DNA Methylation?
DNA methylation is a biochemical process where a methyl group (a molecule made of carbon and hydrogen) attaches to the cytosine base of DNA.
This process controls gene activity without changing the actual genetic code. It helps cells know which genes to turn “on” or “off,” which is essential for growth, repair, and normal functioning.
DNA methylation is important for:
- Gene Regulation: methylation acts like a switch, potentially silencing genes associated with inflammation or tumor growth.
- Normal Development and Disease Prevention: it plays a key role in fetal development, immune health, and healthy aging.
- Disease Onset: when methylation goes wrong, it can either silence important protective genes or activate harmful ones, leading to diseases like cancer or autoimmune disorders.
Clinicians often describe DNA methylation to their patients as a “dimmer switch” for genes, adjusting how much a gene is expressed. If this 'switch' malfunctions, it may contribute to the development of conditions such as neurodegeneration or cancer.
Why Methylation Status Matters in Clinical Practice
Abnormal methylation patterns are emerging as critical biomarkers for many diseases:
Cancer
DNA methylation is one of many factors that influence gene regulation and may play a role in disease development. Tumor suppressor genes (e.g., MGMT, BRCA1) can be “turned down” by hypermethylation, leading to uncontrolled cell growth.
Neurodegenerative Disorders
Methylation changes in genes related to Alzheimer’s disease (AD), like the amyloid precursor protein (APP) gene, may predict disease progression.
For example, in AD, the APP gene can have lower levels of methylation, which leads to higher APP production and more amyloid-beta (Aβ) buildup, a key factor in AD.
Changes in APP methylation can be affected by age, gender, and tissue type, showing how epigenetic changes play a role in the disease.
Autoimmune Diseases
Abnormal methylation can alter immune responses, leading to conditions such as systemic lupus erythematosus (SLE).
Cardiometabolic Conditions
Elevated homocysteine levels related to methylation errors increase cardiovascular and diabetes risk.
Mood Disorders
Methylation, which controls how genes are turned on or off, can affect brain chemicals and hormones.
Problems with methylation, influenced by things like genetics, diet, and lifestyle, have been connected to mood disorders like anxiety, depression, bipolar disorder, and schizophrenia, making it an important focus for improving mental health.
Optimizing Health
Methylation affects normal processes such as detoxification and hormone balance, which are essential for optimal health.
Key Takeaway: because methylation can have such far-reaching influences, clinicians can use methylation testing to uncover early disease markers and personalize treatments, and also to monitor therapy responses.
Overview of Advanced Methylation Assessment Technology
Various methods are available to assess methylation status. While many of the techniques discussed here are primarily used in research settings, some may become more applicable to clinical practice as technology advances and costs decrease.
The technologies discussed here are primarily research tools and may not be FDA-approved for standard clinical use; current clinical applications rely on simpler methods that assess potential methylation capacity or related biomarkers.
The following technologies for advanced methylation testing assess whether a person’s genes have actually been methylated. Examples of these technologies include:
Bisulfite Sequencing
This is the gold standard for assessing actual DNA methylation at specific DNA bases, but it’s expensive and takes a long time to process, so it’s mainly used in research or advanced oncology or genetics labs.
Digital Droplet PCR (ddPCR)
Measures methylation at specific DNA spots with high accuracy; great for finding cancers early and monitoring progress because it’s quick and precise.
Whole-Genome Bisulfite Sequencing (WGBS)
Creates a complete map of methylation across the entire genome, mainly used for research or precision medicine due to its high cost and complexity.
Methylation-Specific PCR (MS-PCR)
Focuses on specific areas of DNA to check for methylation, often used to look at genes linked to cancer or autoimmune diseases. It’s less comprehensive because it doesn’t check the entire genome, but it can be useful diagnostically.
Epigenetic Microarrays
Tests thousands of DNA sites at once, making it a cost-effective choice for big studies and identifying patterns in groups of people.
Nanopore Sequencing
Nanopore sequencing identifies DNA methylation by analyzing electrical signals from single DNA molecules, offering detailed, real-time insights into gene regulation and disease-related changes. However, it’s not widely used in clinics yet.
Clinical Applications of Methylation Testing
Given that many of the advanced methylation assessment technologies discussed above are not widely available to clinicians at this time, what can we rely on for accurate assessment of our patients’ methylation status?
Let’s begin to understand this by distinguishing between what is actually being tested. The above advanced technologies look at actual DNA strands to see whether they have been methylated, so doctors and patients can know whether specific genes (for example, tumor suppressor genes) have been “turned on or off."
While this level of testing is not commonly available in clinical practice yet, there are important ways to identify and interpret a patient’s capacity for methylation. These tests are intended to complement, not replace, standard diagnostic and treatment protocols and should be interpreted in consultation with a qualified healthcare provider.
Methylation testing may provide insights into potential imbalances, offering information that could guide personalized health strategies as part of a comprehensive clinical evaluation. Clinically available testing options include:
Methylation Genomic Testing
Methylation genomic testing is increasingly offered by many companies. This test looks at specific genetic differences (single nucleotide polymorphisms, or SNPs) that affect how well your body can methylate, helping to understand how these differences might impact your methylation process.
Methylation genomic testing can provide the following insights:
- Personalized Care: identifies genetic weaknesses in methylation to guide nutrition and supplements, like methylated B vitamins (folate and B12).
- Mental Health: helps explain links between methylation issues and conditions like depression or anxiety, allowing for targeted support.
- Detox Support: reveals how well the body processes toxins, helping reduce risks of overload and oxidative stress.
- Hormone Balance: guides estrogen metabolism strategies, reducing risks of hormonal imbalances or related conditions.
- Chronic Disease Risk Reduction: provides insights into risks for heart disease, cancer, or autoimmune disorders, supporting early intervention.
Key SNPs Tested
- MTHFR (C677T, A1298C): impacts folate activation for methylation, and may lead to elevated homocysteine. Findings may inform decisions about nutrient supplementation under the guidance of a healthcare provider.
- COMT (Val158Met): affects breakdown of dopamine, stress hormones, and estrogen, influencing mood, stress response, and hormones.
- MTR/MTRR: impacts recycling of homocysteine into methionine, important for methylation. These SNPs also affect vitamin B12 utilization.
- CBS: affects sulfur metabolism and homocysteine turnover. May direct detoxification strategies.
- BHMT: affects an alternate methylation pathway using betaine.
- FOLR1: FOLR1 helps cells take in folate, which is important for making and repairing DNA and for methylation, especially when the body needs more folate or doesn't have enough. Directs folate intake through diet or supplementation.
Examples of Tests Offered
The DNA Methylation Pathway Profile by Mosaic Diagnostics checks important nutrients and chemicals involved in methylation to find possible problems in how the body processes methylation.
The Methylation Genomics by Genova Diagnostics test looks at specific genetic variations related to methylation to give personalized information about how well someone’s body handles this process.
The DNA Methylation by Doctor's Data test examines overall DNA methylation patterns to detect possible imbalances that could affect health or increase disease risk.
The MethylDetox Profile by Cell Science Systems studies genetic differences and nutrient pathways to spot issues with detoxification and methylation that may impact health.
Biomarkers to Test Methylation Status
While genetic testing offers insight into a person’s potential for methylation problems, certain biomarkers can show patterns that more closely reflect a person’s actual methylation status.
Key Biomarkers Tested
- Methionine: shows how much of the building block for methylation is available.
- Cysteine: indicates how well sulfur metabolism and detoxification are working.
- SAM-e (S-adenosylmethionine): the main provider of methyl groups for important body functions.
- SAH (S-adenosylhomocysteine): a byproduct of methylation that can slow the methylation cycle if levels are too high.
- Homocysteine: elevated levels may indicate potential issues with methylation or suggest a need for specific nutrient interventions.
- Cystathionine: can help identify problems in how the body processes methionine and balances methylation. It can also point to vitamin B-6 deficiency, inflammation, and risks like heart disease, making it a helpful tool for checking overall metabolic health and guiding treatment.
- Methylation index (SAM/SAH ratio): provides an overview of methylation activity, and low ratios may indicate potential imbalances.
Biomarkers provide supportive information about methylation but are not standalone diagnostic tools.
Examples of Tests Offered
While some lab companies may offer these biomarkers as individual tests, this is also available as a comprehensive panel in the Methylation Profile by Doctor’s Data.
This test connects a person’s genetic tendencies for methylation issues with how factors like diet, lifestyle, and medications influence their genetic potential.
When to Consider Methylation Testing and Its Role in Clinical Practice
Methylation testing may be a helpful tool for individuals with complex or unexplained health concerns, such as infertility, recurrent pregnancy loss, heart problems, memory issues, mood disorders, or chronic fatigue, as part of a broader clinical evaluation.
It is also useful for those with a family history of these conditions or for patients with signs of high homocysteine levels, inflammation, or impaired detoxification.
This testing provides insight into whether a person’s methylation process is functioning properly. With this information, clinicians can create personalized plans that include tailored nutrition, supplements, and lifestyle changes to address underlying imbalances.
Methylation testing may be considered as part of a comprehensive clinical evaluation for complex health issues.
Methylation assessment offers targeted support in several key areas:
Personalized Nutrition
Understanding a patient’s genetic methylation capacity may help guide nutrition recommendations or supplementation of methyl donors like folate, B12, and betaine based on functional deficiencies.
Cardiometabolic Health
Elevated homocysteine is a risk factor for heart disease; this test identifies the need for heart-healthy interventions to lower levels, and may reveal benefit from additional methylation support.
Mental Health
SAM-e and homocysteine levels are linked to neurotransmitter production and mood regulation; addressing these may support mental health.
Detoxification Support
Methylation problems can indicate a reduced capacity for detoxification, guiding antioxidant or sulfur-rich interventions.
Chronic Disease Prevention
By identifying methylation imbalances, clinicians may help reduce risks for cancer, autoimmune diseases, and neurodegenerative disorders like Alzheimer's disease.
Fertility Support
Patients struggling with recurrent pregnancy loss, pre-eclampsia, and spina bifida may gain greater insight into their situation, particularly in folate-deficient individuals.
The Future of Methylation Testing in Healthcare
Methylation testing represents a promising advancement in personalized healthcare. It may provide insights into complex health conditions and support tailored treatment strategies when used alongside other diagnostic tools.
While advanced testing methods are not yet common due to cost and technology limits, currently available tests are increasingly used by functional medicine providers to individualize and optimize their patients’ treatment plans.
As these tests become more available and affordable, they may become even more commonly used, giving doctors and patients the tools they need for better, more effective treatments and healthier lives.
Methylation testing shows promise for enhancing personalized healthcare, but its widespread clinical adoption depends on further validation and accessibility.
[signup]
Key Takeaways
- Role of Methylation Testing: Methylation testing provides insights into gene regulation and its potential effects on health, aiding in personalized care when part of a broader clinical evaluation.
- Clinical Applications: Testing may help identify imbalances relevant to chronic conditions, mental health, cardiovascular health, detoxification, and fertility.
- Technology Limitations: Advanced methylation assessment tools are primarily research-focused and not widely available for routine clinical use.
- Biomarkers and SNPs: Biomarker and SNP testing can offer valuable context for understanding methylation capacity and informing targeted interventions.
- Consultation Is Key: Professional interpretation ensures the safe and effective use of methylation testing insights in clinical practice.
%201.svg){kind=logo}
